97. 潰瘍性大腸炎
[臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-004610-27-SK
(EUCTR)
06/04/200909/02/2009A double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitisA double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitis Mild to moderate active ulcerative colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: Dersalazine sodium
Product Code: UR-12746-S
INN or Proposed INN: dersalazine sodium
Trade Name: Lixacol
Product Name: Lixacol
INN or Proposed INN: Mesalazine
Trade Name: Lixacol
Product Name: Lixacol
INN or Proposed INN: mesalazine
Palau Pharma S.A.NULLNot RecruitingFemale: yes
Male: yes
90Phase 2Hungary;Slovakia;Spain;Belgium
2EUCTR2008-004610-27-HU
(EUCTR)
26/02/200915/12/2008A double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitisA double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitis Mild to moderate active ulcerative colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: Dersalazine sodium
Product Code: UR-12746-S
INN or Proposed INN: dersalazine sodium
Trade Name: Lixacol
Product Name: Lixacol
INN or Proposed INN: Mesalazine
Trade Name: Lixacol
Product Name: Lixacol
INN or Proposed INN: mesalazine
Palau Pharma S.A.NULLNot RecruitingFemale: yes
Male: yes
90Phase 2Hungary;Belgium;Spain
3EUCTR2008-004610-27-BE
(EUCTR)
02/12/200824/07/2008A double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitisA double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitis Mild to moderate active ulcerative colitis
MedDRA version: 9.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis
Product Name: Dersalazine sodium
Product Code: UR-12746-S
INN or Proposed INN: dersalazine sodium
Trade Name: Lixacol
Product Name: Lixacol
INN or Proposed INN: Mesalazine
Trade Name: Lixacol
Product Name: Lixacol
INN or Proposed INN: mesalazine
Palau Pharma S.A.NULLNot RecruitingFemale: yes
Male: yes
90Phase 2Hungary;Belgium;Spain